QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD. Financials Qinghai Spring Medicinal Resources Technology Co., Ltd.
Equities
600381
CNE0000017W0
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.54 CNY | +5.83% |
|
+5.83% | -41.27% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,376 | 3,164 | 5,055 | 4,949 | 7,227 | 4,538 |
| Enterprise Value (EV) 1 | 2,442 | 2,826 | 4,842 | 4,750 | 7,062 | 4,384 |
| P/E ratio | 47.8 x | 539 x | -15.9 x | -20.1 x | -25.1 x | -16.8 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 10.1 x | 13.5 x | 40.7 x | 38.7 x | 45.1 x | 21.2 x |
| EV / Revenue | 7.33 x | 12.1 x | 39 x | 37.2 x | 44.1 x | 20.5 x |
| EV / EBITDA | -185 x | -150 x | -48.4 x | -28 x | -42 x | -50.9 x |
| EV / FCF | -13.6 x | 12.6 x | -20.1 x | -56.7 x | 127 x | 61.1 x |
| FCF Yield | -7.36% | 7.91% | -4.98% | -1.76% | 0.79% | 1.64% |
| Price to Book | 1.42 x | 1.32 x | 2.44 x | 2.72 x | 4.71 x | 3.49 x |
| Nbr of stocks (in thousands) | 588,075 | 587,061 | 587,061 | 587,061 | 587,061 | 587,061 |
| Reference price 2 | 5.740 | 5.390 | 8.610 | 8.430 | 12.31 | 7.730 |
| Announcement Date | 4/18/19 | 4/29/20 | 4/29/21 | 4/25/22 | 4/28/23 | 4/22/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 333 | 233.7 | 124.3 | 127.8 | 160.2 | 213.9 |
| EBITDA 1 | -13.22 | -18.81 | -100 | -169.7 | -168.2 | -86.13 |
| EBIT 1 | -54.04 | -57.48 | -139.7 | -209.9 | -207.7 | -107.8 |
| Operating Margin | -16.23% | -24.59% | -112.43% | -164.28% | -129.7% | -50.41% |
| Earnings before Tax (EBT) 1 | 63.65 | -1.722 | -315 | -252.5 | -295.3 | -260.3 |
| Net income 1 | 68.45 | 5.808 | -319.5 | -248.6 | -287.5 | -267.9 |
| Net margin | 20.55% | 2.48% | -257.14% | -194.59% | -179.52% | -125.24% |
| EPS 2 | 0.1200 | 0.0100 | -0.5400 | -0.4200 | -0.4900 | -0.4600 |
| Free Cash Flow 1 | -179.7 | 223.5 | -241.1 | -83.72 | 55.74 | 71.77 |
| FCF margin | -53.96% | 95.6% | -194.04% | -65.53% | 34.8% | 33.56% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | 3,847.49% | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/18/19 | 4/29/20 | 4/29/21 | 4/25/22 | 4/28/23 | 4/22/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 933 | 338 | 213 | 198 | 164 | 154 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -180 | 223 | -241 | -83.7 | 55.7 | 71.8 |
| ROE (net income / shareholders' equity) | 2.92% | 0.24% | -14.3% | -12.8% | -17.1% | -19% |
| ROA (Net income/ Total Assets) | -1.39% | -1.48% | -3.78% | -6.47% | -7.62% | -4.62% |
| Assets 1 | -4,934 | -391.6 | 8,444 | 3,842 | 3,773 | 5,801 |
| Book Value Per Share 2 | 4.050 | 4.070 | 3.520 | 3.100 | 2.610 | 2.220 |
| Cash Flow per Share 2 | 0.5300 | 0.4700 | 0.3100 | 0.2800 | 0.2900 | 0.3000 |
| Capex 1 | 43.5 | 5.29 | 198 | 122 | 0.82 | 13.5 |
| Capex / Sales | 13.07% | 2.26% | 159.04% | 95.33% | 0.51% | 6.33% |
| Announcement Date | 4/18/19 | 4/29/20 | 4/29/21 | 4/25/22 | 4/28/23 | 4/22/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -41.27% | 368M | |
| +39.33% | 6.11B | |
| -18.38% | 4.35B | |
| -9.17% | 3.19B | |
| +3.98% | 3.15B | |
| -3.41% | 2.51B | |
| +48.74% | 1.98B | |
| -4.82% | 1.74B | |
| -1.24% | 1.63B | |
| -8.96% | 1.6B |
- Stock Market
- Equities
- 600381 Stock
- Financials Qinghai Spring Medicinal Resources Technology Co., Ltd.
